Tue, Feb 6, 2024 1:43 AM
Penny Stocks To Watch Out On Tuesday – February 06, 2024
A Flip by Shubhangi Gupta
Reported Standalone quarterly numbers for Mangalam Drugs & Organics are: Net Sales at Rs 79.94 crore in September 2024 down 1.98% from Rs. 81.56 crore in September 2023. Quarterly Net Profit at Rs. 2.69 crore in September 2024 up 175.46% from Rs. 3.56 crore in September 2023. EBITDA stands at Rs. 8.83 crore in September 2024 up 297.75% from Rs. 2.22 crore in September 2023.
Open Flip
Reported Standalone quarterly numbers for Nectar Lifesciences are: Net Sales at Rs 428.10 crore in September 2024 up 7.57% from Rs. 397.96 crore in September 2023. Quarterly Net Profit at Rs. 5.60 crore in September 2024 up 451.45% from Rs. 1.02 crore in September 2023. EBITDA stands at Rs. 44.02 crore in September 2024 up 17.48% from Rs. 37.47 crore in September 2023.
Open Flip
Concord Drugs reported Q2 2024 results with a 60.4% increase in net sales to Rs 11.84 crore, but a 89.71% decline in net profit to Rs 0.05 crore, and a 47.71% decrease in EBITDA to Rs 0.80 crore, resulting in a decreased EPS of Rs 0.05. Concord Drugs shares closed at 36.00 on November 25, 2024, with -5.11% returns over the last 6 months.
Open Flip
